Veterinary Medicines Information website

ALPHA JECT 6-2 injeksjonsvæske, emulsjon, vaksine til atlantisk laks

Authorised
  • Infectious pancreatic necrosis virus, serotype Sp, Inactivated
  • Moritella viscosa, Inactivated
  • Vibrio anguillarum, serotype O2a, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Aliivibrio salmonicida, Inactivated
  • Aeromonas salmonicida, subsp. salmonicida, Inactivated
Download as PDF

Product identification

Medicine name:
ALPHA JECT 6-2 injeksjonsvæske, emulsjon, vaksine til atlantisk laks
Active substance:
  • Infectious pancreatic necrosis virus, serotype Sp, Inactivated
  • Moritella viscosa, Inactivated
  • Vibrio anguillarum, serotype O2a, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Aliivibrio salmonicida, Inactivated
  • Aeromonas salmonicida, subsp. salmonicida, Inactivated
Target species:
  • Atlantic salmon
Route of administration:
  • Intraperitoneal use

Product details

Active substance and strength:
  • Infectious pancreatic necrosis virus, serotype Sp, Inactivated
    0.20
    antigen unit(s)
    /
    0.10
    millilitre(s)
  • Moritella viscosa, Inactivated
    60.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Vibrio anguillarum, serotype O2a, Inactivated
    75.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Vibrio anguillarum, serotype O1, Inactivated
    75.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Aliivibrio salmonicida, Inactivated
    90.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
  • Aeromonas salmonicida, subsp. salmonicida, Inactivated
    80.00
    Relative Percentage Survival
    /
    0.10
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Atlantic salmon
      • Meat and offal
        0
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmaq AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmaq AS
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 02-1370
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 14/04/2026
Download